Laura E. Dichtel
Massachusetts General Hospital
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Laura E. Dichtel as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 08:10 UTC. Open this list on ClinicalTrials.gov
- Ph2NCT05364684 · The Impact of Ibutamoren on Nonalcoholic Fatty Liver DiseaseMassachusetts General Hospital · completed · NAFLD, Nonalcoholic Fatty Liver, NASH - Nonalcoholic Steatohepatitis · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 08:10 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
- Metabolomic Investigation of the Impact of Growth Hormone on Nonalcoholic Fatty Liver Disease: Identification of Novel Biomarkers and Therapeutic TargetsR03DK129635 · NIDDK · MASSACHUSETTS GENERAL HOSPITAL · fiscal years 2022 to 2023 · $126,000 awarded in 2023Same name and institution; not confirmed by an ID
- The Growth Hormone and Insulin-like Growth Factor-1 Axis in Nonalcoholic Fatty Liver Disease and Nonalcoholic SteatohepatitisK23DK113220 · NIDDK · MASSACHUSETTS GENERAL HOSPITAL · fiscal years 2017 to 2021 · $72,706 awarded in 2021Same name and institution; not confirmed by an ID
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 08:10 UTC. The ranking covers the 200 most relevant of 8 PubMed records, and a shared surname and initials can bring in a namesake. All 8 on PubMed
- 86 citationsRCR 11.7
- Effect of Testosterone on Natriuretic Peptide Levels.J Am Coll Cardiol · 201941 citationsRCR 1.9
- Effects of Open-Label, Adjunctive Ganaxolone on Persistent Depression Despite Adequate Antidepressant Treatment in Postmenopausal Women: A Pilot Study.J Clin Psychiatry · 202036 citationsRCR 2.1
- Growth Hormone Administration Improves Nonalcoholic Fatty Liver Disease in Overweight/Obesity: A Randomized Trial.J Clin Endocrinol Metab · 202326 citationsRCR 3.1
- Low-Dose Testosterone Augmentation for Antidepressant-Resistant Major Depressive Disorder in Women: An 8-Week Randomized Placebo-Controlled Study.Am J Psychiatry · 202023 citationsRCR 1.6
- The Glucagon-Like Peptide-1 Receptor Agonist, Semaglutide, for the Treatment of Nonalcoholic Steatohepatitis.Hepatology · 202116 citationsRCR 1.0
- The effect of growth hormone on bioactive IGF in overweight/obese women.Growth Horm IGF Res · 20187 citationsRCR 0.4
- Impact of GH administration on skeletal endpoints in adults with overweight/obesity.Eur J Endocrinol · 20226 citationsRCR 0.6